New York’s insurance regulator just did something most states haven’t: it finished the job. On September 4, 2026, the state Department of Financial Services approved final 2027 health insurance premiums for the individual and small-group markets, and the number that survived is a fraction of what insurers originally asked for. If you’ve seen headlines this fall warning that premiums are “going up 15 percent” or more, this is a reminder that a rate request and a rate increase are two different things.
What DFS Actually Cut
In the individual market, insurers had asked New York regulators to approve an average rate increase of 20.6 percent for 2027. DFS approved 6.0 percent instead, a reduction of 71 percent from what was requested, according to the department’s own announcement. In the small-group market, where many workers at small businesses get coverage, insurers requested 23.7 percent and DFS approved 8.0 percent, a cut of 66 percent.
Put together, DFS says the two decisions save New York consumers and small businesses roughly $1.6 billion compared to what insurers had proposed. The department breaks that down as about $324 million saved for individual-market enrollees and about $1.25 billion for small-group enrollees, covering an estimated 860,000 people across both markets.
Free retirement updates: Want plain-English help keeping more of your money in retirement? The free Retirement Shield newsletter covers the benefits, deadlines, and money mistakes that cost retirees, a couple times a week. Subscribe free.
Why the Requested Number Was Never the Real Number
Every fall, insurers in states with “prior approval” laws file the rate increase they’d like to charge the following year. New York is one of those states, which means an insurer can’t simply raise individual and small-group premiums by whatever it wants; DFS has to sign off first, and it can approve something lower than what was asked. That’s exactly what happened here. The 20.6 percent and 23.7 percent figures that circulated over the summer were opening asks, built on insurers’ own projections of medical costs, prescription drug prices, and claims trends. They were never a guarantee of what a policyholder would actually pay.
That distinction matters beyond New York, too. The Peterson-KFF Health System Tracker, which reviews individual-market rate filings nationwide, found a median proposed increase of 15 percent for 2027 across insurers in all 50 states and Washington, D.C., in an analysis updated August 3. That’s a request, not a final rate, and every state runs its own review before any of it becomes real for a household’s bill.
What Insurers Blamed for the Higher Asks
The requests themselves weren’t arbitrary. Insurers filing in New York and elsewhere have pointed to a familiar mix of pressures: rising hospital and prescription drug prices, contract renegotiations with providers, and a sicker average enrollee pool after federal enhanced premium tax credits expired at the end of 2025, which pushed healthier people to drop individual-market coverage and left a costlier group behind. Some insurers also cited the growing cost of GLP-1 weight-loss and diabetes drugs as a specific line item driving their asks higher. None of that disappears just because DFS approved a smaller number than requested; it just means New York’s regulator judged that insurers had padded their asks beyond what the actual cost pressures justified.
Other States Are Still Deciding
New York’s approval landed weeks ahead of where several other states currently stand. Pennsylvania’s insurance department said in July that insurers there were requesting an average 17.1 percent increase in the individual market and 11.5 percent in the small-group market, and that it would spend the summer reviewing those filings, with final approved rates not made public until fall. Consumers in states still mid-review won’t know their actual 2027 premium until their own regulator finishes that process, which can move the number up, down, or leave it largely unchanged depending on how aggressively that state’s law lets regulators push back.
What the Cut Doesn’t Mean
A 6 percent approved increase is still an increase, not a freeze, and it isn’t the same for every plan. DFS’s own summary breaks the totals down by individual carrier, and some insurers came in above or below the 6.0 and 8.0 percent averages depending on their specific claims experience and product mix. Anyone shopping individual or small-group coverage in New York for 2027 will want to check their specific plan’s approved rate rather than assume the statewide average applies to them, since carrier-level results vary inside that average. It’s also worth remembering this approval covers only the individual and small-group markets DFS regulates directly; large-employer plans and self-funded employer coverage, which cover far more New Yorkers, follow a different process and aren’t part of this decision.
The Bigger Pattern to Watch
What makes New York’s move notable isn’t just the size of the cut, it’s the timing. DFS finished its review and made its decision public before most other prior-approval states had closed theirs out, giving New Yorkers a real number while people elsewhere are still working from an insurer’s opening bid. As more states finish their own 2027 reviews over the coming weeks, the gap between what was requested nationally and what regulators actually approve is likely to be the more useful number for household budgeting than any single state’s initial filing. For now, New York offers the clearest evidence yet that a scary summer headline about a 20-percent-plus ask doesn’t automatically become the bill that lands in a mailbox.
This article was produced with AI assistance and reviewed by a human editor. Figures are linked to their primary sources; where a claim could not be verified from the public record, we say so.
More Financial Reading
